Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process
Оценка выхода scFv-белка из E. coli при помощи рефолдинга in vitro и мягкой солюбилизации
2019-01-14
SCID: 54.1/he5qadsc
Discuss with AI
E. coli inclusion bodiesin vitro refoldingmaltose-binding proteinmild solubilizationscFv antibody
Figures from the paper
Abstract (AI)
BACKGROUND: The production of therapeutically active single chain variable fragment (scFv) antibody is still challenging in E. coli due to the aggregation propensity of recombinant protein into inclusion bodies (IBs). However, recent advancement of biotechnology has shown substantial recovery of bioactive protein from such insoluble IBs by solubilization and refolding processes. In addition, gene fusion technology has also widely been used to improve the soluble protein production using E. coli. This study demonstrates that mild-solubilization and in vitro refolding strategies, both are capable to recover soluble scFv protein from bacterial IBs, although the degree of success is greatly influenced by different fusion tags with the target protein. RESULTS: It was observed that the most commonly used fusion tag, i.e., maltose binding protein (MBP) was not only influenced the cytoplasmic expression in E. coli but also greatly improved the in vitro refolding yield of scFv protein. On the other hand, mild solubilization process potentially could recover soluble and functional scFv protein from non-classical IBs without assistance of any fusion tag and in vitro refolding step. The recovery yield achieved by mild solubilization process was also found higher than denaturation-refolding method except while scFv was refolded in fusion with MBP tag. Concomitantly, it was also observed that the soluble protein achieved by mild solubilization process was better structured and functionally more active than the one achieved by in vitro refolding method in the absence of MBP tag or refolding enhancer. CONCLUSIONS: Maltose binding protein tagged scFv has shown better refolding and solubility yields as compare to mild solubilization process. However, in terms of cost, time and tag free nature, mild solubilization method for scFv recovery from bacterial IBs is considerable for therapeutic application and further structural studies.
Key Findings
1
Both mild solubilization and in vitro refolding recovered soluble scFv from E. coli inclusion bodies, with success strongly dependent on the fusion tag.
2
MBP fusion enhanced cytoplasmic scFv expression and substantially improved in vitro refolding yield.
3
Mild solubilization generally produced higher recovery than denaturation–refolding, except for scFv refolded as an MBP fusion.
4
Mild solubilization recovered soluble, functional scFv from non-classical inclusion bodies without fusion tags or a refolding step.
5
Without MBP or a refolding enhancer, mildly solubilized scFv was better structured and more functionally active than refolded protein; its lower cost, shorter processing time, and tag-free nature support therapeutic and structural applications.
Research Object
Recombinant single-chain variable fragment (scFv) antibody protein produced in E. coli and accumulated in bacterial inclusion bodies
Research Subject
Recovery of soluble, properly structured, and functionally active scFv from inclusion bodies by mild solubilization and in vitro refolding, including the influence of fusion tags such as MBP
Publication Details
Publication Date
2019-01-14
Journal
Publisher
ISSN
Cited by
75
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest